Detalles de la búsqueda
1.
High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study.
Haematologica;
108(8): 2091-2100, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36632738
2.
The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation.
Haematologica;
107(4): 868-876, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34092056
3.
Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study.
Blood;
138(25): 2727-2730, 2021 12 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34587233
4.
Impact of exclusion criteria for the DASISION and ENESTnd trials in the front-line treatment of a 'real-life' patient population with chronic myeloid leukaemia.
Hematol Oncol;
35(2): 232-236, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26648184
5.
Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartments.
Br J Haematol;
172(3): 371-383, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26597680
6.
Can chronic myeloid leukaemia in children and adolescents be successfully treated without haematopoietic stem cell transplant? A single centre experience.
Br J Haematol;
173(5): 749-53, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26913809
7.
Long-term results of high-dose imatinib in children and adolescents with chronic myeloid leukaemia in chronic phase: the Italian experience.
Br J Haematol;
170(3): 398-407, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25891192
8.
High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2).
Haematologica;
105(11): 2671-2674, 2020 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33131259
9.
Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression.
Blood;
119(17): 4034-46, 2012 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-22327224
10.
Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome.
Blood;
119(10): 2219-27, 2012 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-22262773
11.
Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients' prognosis.
Am J Hematol;
89(1): 74-82, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24030933
12.
Atypical Chronic Myeloid Leukemia in a Patient with Aplastic Anemia.
Acta Haematol;
142(3): 185-186, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31112981
13.
Early response does not predict outcome in children and adolescents with chronic myeloid leukaemia treated with high-dose imatinib.
Br J Haematol;
180(6): 895-898, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27984633
14.
Complete clearance of Ph+ metaphases after 3 months is a very early indicator of good response to imatinib as front-line treatment in chronic myelogenous leukemia.
Acta Haematol;
129(2): 126-34, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23207803
15.
Behind the scenes of non-nodal MCL: downmodulation of genes involved in actin cytoskeleton organization, cell projection, cell adhesion, tumour invasion, TP53 pathway and mutated status of immunoglobulin heavy chain genes.
Br J Haematol;
156(5): 601-11, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22150124
16.
ATM gene alterations in chronic lymphocytic leukemia patients induce a distinct gene expression profile and predict disease progression.
Haematologica;
97(1): 47-55, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21993670
17.
Evaluation of TP53 mutations with the AmpliChip p53 research test in chronic lymphocytic leukemia: correlation with clinical outcome and gene expression profiling.
Genes Chromosomes Cancer;
50(4): 263-74, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21319261
18.
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia.
Genes Chromosomes Cancer;
50(8): 633-43, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21563234
19.
Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA CML WP.
Blood;
114(24): 4939-43, 2009 Dec 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-19797518
20.
White blood cell count at diagnosis and immunoglobulin variable region gene mutations are independent predictors of treatment-free survival in young patients with stage A chronic lymphocytic leukemia.
Haematologica;
96(4): 626-30, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21193417